Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan O'Brien

Showing results (61-70 of 643) with videos related to

Pageof 65
Sort By:
Expert Review of Hematology|May 2, 2024
Are we closer to a standard of care for Richter's syndrome? Novel treatments on the horizonNghia Pham, Catherine C Coombs, Susan O'Brien
Pediatrics|June 5, 2003
Methadone and breastfeeding: new horizonsBarbara L Philipp, Anne Merewood, Susan O'Brien
Lancet (London, England)|July 28, 2024
Chronic lymphocytic leukaemiaNitin Jain, William G Wierda, Susan O'Brien
Seminars in Oncology|February 14, 2002
Emerging information on the use of rituximab in chronic lymphocytic leukemiaMichael J Keating, Susan O'Brien, Maher Albitar
Best Practice & Research. Clinical Haematology|September 26, 2006
Monoclonal antibody combinations in CLL: evolving strategiesStefan Faderl, Susan O'Brien, Michael J Keating
Expert Review of Hematology|July 17, 2020
Mechanisms of ibrutinib resistance in chronic lymphocytic leukemia and alternative treatment strategiesTsering Gyalpo Lama, Daniel Kyung, Susan O'Brien
Expert Opinion on Emerging Drugs|January 9, 2010
Emerging therapy for the treatment of acute lymphoblastic leukemiaAmber Fullmer, Susan O'Brien, Hagop Kantarjian, et al.
Hemasphere|February 26, 2026
Is CLL curable?Nitin Jain, Alessandra Ferrajoli, Susan O'Brien, et al.
Synapse (New York, N.Y.)|June 27, 2003
GABAA receptor-mediated neurotransmission in the dentate gyrus of the rhesus monkey: comparison with the ratSusan O'Brien, Douglas L Rosene, Jennifer I Luebke
Current Hematologic Malignancy Reports|April 29, 2010
Novel therapies for relapsed acute lymphoblastic leukemiaAmber Fullmer, Susan O'Brien, Hagop Kantarjian, et al.
Pageof 65

Showing results (61-70 of 643) with videos related to

Sort By:
Pageof 65
Expert Review of Hematology|May 2, 2024
Are we closer to a standard of care for Richter's syndrome? Novel treatments on the horizonNghia Pham, Catherine C Coombs, Susan O'Brien
Pediatrics|June 5, 2003
Methadone and breastfeeding: new horizonsBarbara L Philipp, Anne Merewood, Susan O'Brien
Lancet (London, England)|July 28, 2024
Chronic lymphocytic leukaemiaNitin Jain, William G Wierda, Susan O'Brien
Seminars in Oncology|February 14, 2002
Emerging information on the use of rituximab in chronic lymphocytic leukemiaMichael J Keating, Susan O'Brien, Maher Albitar
Best Practice & Research. Clinical Haematology|September 26, 2006
Monoclonal antibody combinations in CLL: evolving strategiesStefan Faderl, Susan O'Brien, Michael J Keating
Expert Review of Hematology|July 17, 2020
Mechanisms of ibrutinib resistance in chronic lymphocytic leukemia and alternative treatment strategiesTsering Gyalpo Lama, Daniel Kyung, Susan O'Brien
Expert Opinion on Emerging Drugs|January 9, 2010
Emerging therapy for the treatment of acute lymphoblastic leukemiaAmber Fullmer, Susan O'Brien, Hagop Kantarjian, et al.
Hemasphere|February 26, 2026
Is CLL curable?Nitin Jain, Alessandra Ferrajoli, Susan O'Brien, et al.
Synapse (New York, N.Y.)|June 27, 2003
GABAA receptor-mediated neurotransmission in the dentate gyrus of the rhesus monkey: comparison with the ratSusan O'Brien, Douglas L Rosene, Jennifer I Luebke
Current Hematologic Malignancy Reports|April 29, 2010
Novel therapies for relapsed acute lymphoblastic leukemiaAmber Fullmer, Susan O'Brien, Hagop Kantarjian, et al.
Pageof 65